These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 31487183
21. Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development. He Y, Ho C. J Pharm Sci; 2015 Oct; 104(10):3237-58. PubMed ID: 26175316 [Abstract] [Full Text] [Related]
22. Molecular Simulation and Statistical Learning Methods toward Predicting Drug-Polymer Amorphous Solid Dispersion Miscibility, Stability, and Formulation Design. Walden DM, Bundey Y, Jagarapu A, Antontsev V, Chakravarty K, Varshney J. Molecules; 2021 Jan 01; 26(1):. PubMed ID: 33401494 [Abstract] [Full Text] [Related]
23. Thermal Stability of Amorphous Solid Dispersions. Jelić D. Molecules; 2021 Jan 05; 26(1):. PubMed ID: 33466393 [Abstract] [Full Text] [Related]
24. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance. Indulkar AS, Lou X, Zhang GGZ, Taylor LS. Mol Pharm; 2019 Mar 04; 16(3):1327-1339. PubMed ID: 30669846 [Abstract] [Full Text] [Related]
25. Comparative Assessment of Miniaturized Screening Approaches for Selection of Polymers for Amorphous Drug Stabilization. Banda A, Manchanda A, Zhang W, Alba GM, Nagapudi K. J Pharm Sci; 2018 Mar 04; 107(3):897-908. PubMed ID: 29155235 [Abstract] [Full Text] [Related]
26. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions. Chen Y, Liu C, Chen Z, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F. Mol Pharm; 2015 Feb 02; 12(2):576-89. PubMed ID: 25535667 [Abstract] [Full Text] [Related]
27. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method. Ullrich A, Schiffter HA. Eur J Pharm Biopharm; 2018 Dec 02; 133():20-30. PubMed ID: 30261267 [Abstract] [Full Text] [Related]
28. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization. Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A. Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284 [Abstract] [Full Text] [Related]
29. The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions. DeBoyace K, Wildfong PLD. J Pharm Sci; 2018 Jan 20; 107(1):57-74. PubMed ID: 28389266 [Abstract] [Full Text] [Related]
30. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability. Fridgeirsdottir GA, Harris RJ, Dryden IL, Fischer PM, Roberts CJ. Mol Pharm; 2018 May 07; 15(5):1826-1841. PubMed ID: 29533634 [Abstract] [Full Text] [Related]
31. Refining stability and dissolution rate of amorphous drug formulations. Grohganz H, Priemel PA, Löbmann K, Nielsen LH, Laitinen R, Mullertz A, Van den Mooter G, Rades T. Expert Opin Drug Deliv; 2014 Jun 07; 11(6):977-89. PubMed ID: 24754747 [Abstract] [Full Text] [Related]
32. Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects. Lin X, Hu Y, Liu L, Su L, Li N, Yu J, Tang B, Yang Z. Pharm Res; 2018 Apr 23; 35(6):125. PubMed ID: 29687226 [Abstract] [Full Text] [Related]
33. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance. Chen H, Pui Y, Liu C, Chen Z, Su CC, Hageman M, Hussain M, Haskell R, Stefanski K, Foster K, Gudmundsson O, Qian F. J Pharm Sci; 2018 Jan 23; 107(1):317-326. PubMed ID: 29107047 [Abstract] [Full Text] [Related]
34. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form. Puri V, Dantuluri AK, Bansal AK. J Pharm Sci; 2012 Jan 23; 101(1):342-53. PubMed ID: 21935949 [Abstract] [Full Text] [Related]
35. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions. Hiew TN, Zemlyanov DY, Taylor LS. Mol Pharm; 2022 Feb 07; 19(2):392-413. PubMed ID: 34494842 [Abstract] [Full Text] [Related]
36. Surface Stabilization and Dissolution Rate Improvement of Amorphous Compacts with Thin Polymer Coatings: Can We Have It All? Novakovic D, Peltonen L, Isomäki A, Fraser-Miller SJ, Nielsen LH, Laaksonen T, Strachan CJ. Mol Pharm; 2020 Apr 06; 17(4):1248-1260. PubMed ID: 32027513 [Abstract] [Full Text] [Related]
37. β-Lactoglobulin-based amorphous solid dispersions: A graphical review on the state-of-the-art. Zhuo X, Jasiukenaite I, Löbmann K. Eur J Pharm Biopharm; 2024 Sep 06; 202():114396. PubMed ID: 38971201 [Abstract] [Full Text] [Related]
38. Structural and dynamic properties of amorphous solid dispersions: the role of solid-state nuclear magnetic resonance spectroscopy and relaxometry. Paudel A, Geppi M, Mooter GVD. J Pharm Sci; 2014 Sep 06; 103(9):2635-2662. PubMed ID: 24715618 [Abstract] [Full Text] [Related]
39. Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions. Nambiar AG, Singh M, Mali AR, Serrano DR, Kumar R, Healy AM, Agrawal AK, Kumar D. AAPS PharmSciTech; 2022 Sep 02; 23(7):249. PubMed ID: 36056225 [Abstract] [Full Text] [Related]
40. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions. Ashwathy P, Anto AT, Sudheesh MS. Drug Dev Ind Pharm; 2021 Jan 02; 47(1):1-11. PubMed ID: 33494623 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]